빌리언스

This profile gathers the share dealings of 빌리언스 across 3 companies, led by 경남제약, 사토시홀딩스 and 빌리언스. Between 25 March 2021 and 8 July 2026, the trades on record add up to 36 filings.

On the open market, the record shows 8 purchases and 24 sales. The totals do not cover 32 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 1 purchase and 5 sales.

No cluster: in 6 purchases, no other insider of the company bought within 30 days.

On 8 July 2026 came the latest disclosure, a transaction in 경남제약. The last purchase on record was published on 23 January 2026, which is 268 days ago. The median gap between a trade and its publication by DART (FSS) is 5 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.